Topriceanu, Constantin-Cristian http://orcid.org/0000-0001-5826-9617
Chaturvedi, Nish
Mathur, Rohini http://orcid.org/0000-0002-3817-8790
Garfield, Victoria
Article History
Received: 10 June 2023
Revised: 29 October 2023
Accepted: 28 November 2023
First Online: 5 January 2024
Competing interests
: The views expressed in this article are those of the authors who declare that they have no conflict of interest except for NC who serves on a Data Safety and Monitoring Board for a clinical trial of a glucose lowering agent, funded by AstraZeneca. RM is part of the Genes & Health programme, which is part-funded (including salary contributions) by a Life Sciences Consortium comprising Astra Zeneca PLC, Bristol-Myers Squibb Company, GlaxoSmithKline Research and Development Limited, Maze Therapeutics Inc, Merck Sharp & Dohme LLC, Novo Nordisk A/S, Pfizer Inc, Takeda Development Centre Americas Inc.
: UK Biobank’s ethical approval (11/NW/0382) was from the Northwest Multi-centre Research Committee (MRCEC) in 2011, which was renewed in 2016 and then in 2021. All procedures performed were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.